Cargando…
Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4
Hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC), which required developing novel therapies targeting the inhibition of HBV transcription and replication due to current limited treatment options. We explored novel target for the development of novel therapi...
Autores principales: | Wei, Jie, Shi, Yueyuan, Zou, Chunhong, Zhang, Hongpeng, Peng, Hui, Wang, Shilei, Xia, Lulu, Yang, Yuan, Zhang, Xiang, Liu, Junye, Zhou, Hua, Luo, Miao, Huang, Ailong, Wang, Deqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692152/ https://www.ncbi.nlm.nih.gov/pubmed/34975318 http://dx.doi.org/10.7150/ijbs.62106 |
Ejemplares similares
-
E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3
por: Liu, Junye, et al.
Publicado: (2021) -
The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation
por: Long, Quanxin, et al.
Publicado: (2017) -
Release of hepatitis B virions is positively regulated by glucose‐regulated protein 78 through direct interaction with preS1
por: Shi, Yueyuan, et al.
Publicado: (2022) -
Detection of HBV Covalently Closed Circular DNA
por: Li, Xiaoling, et al.
Publicado: (2017) -
Research progress in hepatitis B virus covalently closed circular DNA
por: Zhang, Xiaodong, et al.
Publicado: (2022)